Challenges and future directions of dual payload antibody–drug conjugates

Publication Details

Journal
Bioconjugation Insights
Published
2025-11-04
DOI
https://doi.org/10.18609/bci.2025.025
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Challenges and future directions of dual payload antibody–drug conjugates

Bioconjugation Insights
HER2/EGFR in Cancer Research
article

Challenges and future directions of dual payload antibody–drug conjugates

article en

Abstract

No abstract available for this paper.
Bioconjugation InsightsVol. 1(4)
Gender equality
Openalex Percentile: Top 34%
HER2/EGFR in Cancer Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Challenges and future directions of dual payload antibody–drug conjugates · Bioconjugation Insights (2025) | TGRS Research Map | TGRS